Astrazeneca Pharmaceuticals Lp is an API and finished-dose manufacturer based in United States. It holds 3 active US drug master files across a filed portfolio of 3 molecules. Its filings concentrate with US FDA, MINSA (CR) and ARCSA (EC). Its GMP standing is certified by ANVISA (Brazil), US FDA and MHRA (UK), among 6 authorities. Its most recent recorded inspection, by US FDA, closed on 3 April 2026 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Mount Vernon, United Arab Emirates | Not on file |
| Philadelphia, United Arab Emirates | Not on file |
| Frederick, United Arab Emirates | Not on file |
| NEWARK, United States | Not on file |
| Frederick, United States | 3002617771 |
| Redwood City, United States | 3011389428 |
6 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Goserelin | US FDA | 2 |
| Metoprolol | US FDA | 1 |
| Sodium Zirconium Cyclosilicate | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 61 | 4 |
| MINSA (CR) | 23 | None |
| ARCSA (EC) | 9 | None |
| INVIMA (CO) | 8 | None |
| NAFDAC (NG) | 4 | 1 |
| SFDA (Saudi Arabia) | 3 | None |
| ANVISA (Brazil) | None | 5 |
| MHRA (UK) | None | 2 |
| FDA (GH) | None | 1 |
| NCELS (KZ) | None | 1 |
Choose your molecules and target markets. Astrazeneca Pharmaceuticals Lp comes back tiered against every other supplier able to file there.
Start for free